Marina Vieira Agostinho Galvani

Marina Vieira Agostinho Galvani

Auto-generated profile, based on publicly available information

Marina Vieira Agostinho Galvani

Fiocruz, IOC

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MPMarina V. A. Pereira
Marina V. A. Pereira
RGRômulo G. Galvani
Rômulo G. Galvani
TGTriciana Gonçalves-Silva
Triciana Gonçalves-Silva
ZVZilton Farias Meira de Vasconcelo
Zilton Farias Meira de Vasconcelo
ABAdriana Bonomo
Adriana Bonomo
The immune system is traditionally classified as a defense system that can discriminate between self and non-self or dangerous and non-dangerous situations, unleashing a tolerogenic reaction or immune response. These activities are mainly coordinated by the interaction between innate and adaptive cells that act together to eliminate harmful stimuli and keep tissue healthy. However, healthy tissue is not always the end point of an immune response. Much evidence has been accumulated over the years, showing that the immune system has complex, diversified, and integrated functions that converge to maintaining tissue homeostasis, even in the absence of aggression, interacting with the tissue cells and allowing the functional maintenance of that tissue. One of the main cells known for their function in helping the immune response through the production of cytokines is CD4+ T lymphocytes. The cytokines produced by the different subtypes act not only on immune cells but also on tissue cells. Considering that tissues have specific mediators in their architecture, it is plausible that the presence and frequency of CD4+ T lymphocytes of specific subtypes (Th1, Th2, Th17, and others) maintain tissue homeostasis. In situations where homeostasis is disrupted, such as infections, allergies, inflammatory processes, and cancer, local CD4+ T lymphocytes respond to this disruption and, as in the healthy tissue, towards the equilibrium of tissue dynamics. CD4+ T lymphocytes can be manipulated by tumor cells to promote tumor development and metastasis, making them a prognostic factor in various types of cancer. Therefore, understanding the function of tissue-specific CD4+ T lymphocytes is essential in developing new strategies for treating tissue-specific diseases, as occurs in cancer. In this context, this article reviews the evidence for this hypothesis regarding the phenotypes and functions of CD4+ T lymphocytes and compares their contribution to maintaining tissue homeostasis in different organs in a steady state and during tumor progression.

26 June 2024 in Revista Brasileira de Cancerologia
Verified
Journal Article
Open access
PDF file
PVPedro Felipe Couto Vieira
Pedro Felipe Couto Vieira
JLJackeline Christiane Pinto Lobato
Jackeline Christiane Pinto Lobato
CMCarla Cristina Pedrosa de Lira de Morais
Carla Cristina Pedrosa de Lira de Morais
RGRômulo Gonçalves Galvani
Rômulo Gonçalves Galvani
MPMarina Vieira Agostinho Pereira
Marina Vieira Agostinho Pereira
ASAmanda Moura de Souza
Amanda Moura de Souza
Introdução: A pandemia de covid-19 alterou a dinâmica de conservação dos enxertos e de realização dos transplantes de células progenitoras hematopoiéticas (TCPH) alogênicos, o que pode ter afetado a sobrevida dos pacientes. Objetivo: Analisar a sobrevida dos pacientes pós-TCPH imediato (100 dias pós-TCPH) segundo a exposição aos diferentes tipos de transplantes e fontes de enxerto, na pré-pandemia e na pandemia de covid-19. Método: Estudo de coorte retrospectivo de base hospitalar com 246 pacientes que realizaram TCPH em hospital de referência no município do Rio de Janeiro entre janeiro/2016 e dezembro/2021. Os métodos de log-rank e Kaplan-Meier foram utilizados para estimar as funções de sobrevida de pós-TCPH imediato. Resultados: A taxa de mortalidade foi ligeiramente superior na pandemia quando comparada à pré-pandemia (10,1% vs. 8,8%). O enxerto mais utilizado em todo o período estudado foi medula óssea (MO) com 85%. Porém, na pandemia, 50,5% das coletas alogênicas foram realizadas utilizando o sangue periférico mobilizado (SPM). Oito por cento dos enxertos criopreservados não foram infundidos. Não foram observadas diferenças na sobrevida entre pacientes que utilizaram SPM como fonte de enxerto em relação à MO. Conclusão: Os tipos de enxerto e as fontes de transplantes não influenciaram a sobrevida dos pacientes em ambos os períodos. A criopreservação se apresentou como uma ferramenta importante para superar os desafios logísticos ligados à pandemia de covid-19, porém, um percentual relevante de enxertos criopreservados não foi utilizado. Assim, é necessário que os centros transplantadores voltem a realizar TCPH com produtos frescos, reduzindo o percentual de inutilização dos enxertos.

2 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
FXFelipe Henrique da Cunha Xavier
Felipe Henrique da Cunha Xavier
IAItauá Leston Araujo
Itauá Leston Araujo
RGRômulo Gonçalves Agostinho Galvani
Rômulo Gonçalves Agostinho Galvani
SPSuelen Martins Perobelli
Suelen Martins Perobelli
PVPedro Henrique Oliveira Vianna
Pedro Henrique Oliveira Vianna
ABAdriana Cesar Bonomo
Adriana Cesar Bonomo
SummaryBackgroundChronic Chagas disease has indeterminate and cardiac forms associated with distinct immune profiles. Infection with SARS-CoV-2, compared with other causes of hospital admission, represented the highest risk factor for in-hospital mortality among patients with Chagas disease during the COVID-19 pandemic. Nevertheless, whether SARS-CoV-2 infection disrupts pre-existing Trypanosoma cruzi-specific immunity and affects cardiac progression remains unclear.MethodsWe investigated adults with chronic Chagas disease followed during the COVID-19 pandemic and stratified by Chagas disease clinical form and COVID-19 status. Clinical progression was assessed during 1-yr follow-up. Peripheral blood mononuclear cells were stimulated with T. cruzi lysate, and antigen-induced CD4 and CD8 T-cell responses were quantified by flow cytometry and expressed as log2 stimulation indices. Serum cytokines, chemokines, growth factors, and cardiovascular risk-associated proteins were measured by multiplex assays. Hierarchical clustering and Spearman correlation networks were used to assess coordinated immune changes.FindingsAmong 172 patients, 37 had mild COVID-19 and 135 had no history of COVID-19. Cardiac progression was more frequent in patients with mild COVID-19 than in those without COVID-19 (16·2% vs 5·2%; adjusted OR 3·64, 95% CI 1·06–12·33; p=0·035). Indeterminate patients without COVID-19 showed IL-10/IL-17/LAP-skewed T. cruzi-specific responses, whereas this profile was reduced in indeterminate patients with COVID-19, in favor of higher IL-1β and enhanced CD8 response. Cardiac patients with COVID-19 retained a Th1-skewed profile, with higher TNF, IL-6, CD4+IFN-γ+ responses, and denser serum networks linking inflammatory cytokines, chemokines, and cardiovascular risk-associated proteins, with a loss of correlations between regulatory and inflammatory T cell populations.InterpretationMild SARS-CoV-2 infection was associated with cardiac progression and immune-network remodeling in chronic Chagas disease, marked by loss of regulatory and Th17 features in indeterminate disease and amplification of inflammatory coordination in cardiomyopathy.FundingFiocruz, FAPERJ, CNPq, CAPES and GIISER (Gates Foundation).

30 June 2025 in SSRN Electronic Journal
Verified
Preprint
Open access
MGMarina Vieira Agostinho Galvani
Marina Vieira Agostinho Galvani
KOKarina da Silva Oliveira
Karina da Silva Oliveira
FXFelipe Henrique da Cunha Xavier
Felipe Henrique da Cunha Xavier
IAItauá Leston Araujo
Itauá Leston Araujo
PLPaulo Correa Leite
Paulo Correa Leite
RGRômulo Gonçalves Agostinho Galvani
Rômulo Gonçalves Agostinho Galvani
Background: Cytokine dysregulation increases severe disease risk. Using inflammatory biomarkers and T/B cell dynamics, we developed predictive machine learning model to identify individuals at high-risk pre-infection.Methods: We conducted a pooled cross-sectional study from two macro projects in Rio de Janeiro, Brazil. Both used qRT-PCR to identify infected patients and classified cases as symptomatic or asymptomatic. Levels of 48 cytokines were quantified, and a machine learning model was developed to predict individuals who would develop symptomatic disease. We also measured T and B cell neogenesis by quantifying TRECs (T-cell Receptor Excision Circles) and KRECs (kappa-Deleting Recombination Excision Circles).Findings: Correlation network modeling revealed distinct immune coordination. Asymptomatic individuals displayed linked cytokine networks associated with antimicrobial humoral immune response mediated by antimicrobial peptide, positive regulation of leukocyte differentiation and lymphocyte mediated immunity, while symptomatic cases exhibited sparse networks, lower humoral immune response and natural killer chemotaxis. The machine learning model identified key cytokines as predictors of disease symptoms, achieving a robust AUC of 0·788, as high as 0·857 in Accuracy, 0·815 in F1-Score, 0·705 in Kappa, 0·792 in Positive Predictive Value and 1 in Negative Predictive Value for prediction of symptomatic risk. Thymic output biomarkers were comparable across groups. However, when B-cell dynamics were assessed, symptomatic individuals showed elevated recent B-cell production (sjKREC levels), while asymptomatic cases exhibited previous clonal B-cell expansions.Interpretation: These findings indicate that the pre-existing immune profile can predict asymptomatic or symptomatic disease. This research highlights the potential of cytokine profiling and machine learning for early risk stratification, aiding vaccine prioritization in future pandemics or seasonal outbreaks.